Your browser doesn't support javascript.
loading
Diminishing returns, increasing risks: Impact of antibiotic duration of therapy on respiratory bacterial isolates in hospitalized patients during the coronavirus disease 2019 (COVID-19) pandemic.
Li, Catherine; Chapin, Ryan W; Mercuro, Nicholas J; Yen, Christina F; Gold, Howard S; Lee, Matthew S L; McCoy, Christopher.
Afiliação
  • Li C; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Chapin RW; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Mercuro NJ; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Yen CF; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Gold HS; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Lee MSL; Silverman Institute for Health Care Quality and Safety, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • McCoy C; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Article em En | MEDLINE | ID: mdl-36168468
ABSTRACT
In 829 hospital encounters for patients with COVID-19, 73.2% included orders for antibiotics; however, only 1.8% had respiratory cultures during the first 3 hospital days isolating bacteria. Case-control analysis of 30 patients and 96 controls found that each antibiotic day increased the risk of isolating multidrug-resistant gram-negative bacteria (MDR-GNB) in respiratory cultures by 6.5%.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article